Cargando…
Spike protein fusion loop controls SARS-CoV-2 fusogenicity and infectivity
The high SARS-CoV-2 reproductive number driving the COVID-19 pandemic has been a mystery. Our recent in vitro, and in vivo coronaviral pathogenesis studies involving Mouse Hepatitis Virus (MHV-A59) suggest a crucial role for a small host membrane-virus contact initiator region of the Spike protein,...
Autor principal: | Pal, Debnath |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919542/ https://www.ncbi.nlm.nih.gov/pubmed/33662570 http://dx.doi.org/10.1016/j.jsb.2021.107713 |
Ejemplares similares
-
Cellular electrical impedance to profile SARS-CoV-2 fusion inhibitors and to assess the fusogenic potential of spike mutants
por: Vanhulle, Emiel, et al.
Publicado: (2023) -
SARS-CoV-2 Delta spike protein enhances the viral fusogenicity and inflammatory cytokine production
por: Ao, Zhujun, et al.
Publicado: (2022) -
SARS-CoV-2 omicron variants harbor spike protein mutations responsible for their attenuated fusogenic phenotype
por: Park, Seung Bum, et al.
Publicado: (2023) -
SARS-CoV-2 infection and viral fusogens cause neuronal and glial fusion that compromises neuronal activity
por: Martínez-Mármol, Ramón, et al.
Publicado: (2023) -
SARS-CoV-2 Omicron subvariants exhibit distinct fusogenicity, but similar sensitivity, to pan-CoV fusion inhibitors
por: Xia, Shuai, et al.
Publicado: (2023)